First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
IDRX, Inc., a wholly owned subsidiary of GSK, LLC
Theseus Pharmaceuticals
Hoffmann-La Roche
Novartis